Proanthocyanidins prevent tau protein aggregation and disintegrate tau filaments

被引:2
|
作者
Yin, Huan-Huan [1 ]
Han, Yin -Lei [1 ]
Yan, Xiao [2 ]
Guan, Yi-Xin [1 ]
机构
[1] Zhejiang Univ, Coll Chem & Biol Engn, Hangzhou 310027, Peoples R China
[2] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany
基金
中国国家自然科学基金;
关键词
Protein; Aggregation; Disaggregation; Molecular simulation; Proanthocyanidins; Alzheimer?s disease (AD); ALZHEIMERS-DISEASE; A-BETA; MECHANISM; OLIGOMERS; INSIGHTS; MODELS;
D O I
10.1016/j.cjche.2022.09.013
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Occurrence of neurofibrillary tangles of the tau protein is a hallmark of tau-related neurodegenerative diseases, i.e. Alzheimer's disease (AD) and frontotemporal dementia. The pathological mechanism under-lying AD remains poorly understood, and effective treatments are still unavailable to mitigate the disease. Inhibiting of tau aggregation and disrupting the existing fibrils are key targets in drug discovery towards preventing or curing AD. In this study, grape seed proanthocyanidins (GSPs) was found to effectively inhi-bit the repeat domain of tau (tau-RD) aggregation and disaggregate tau-RD fibrils in a concentration -dependent manner by inhibiting b-sheet formation of tau-RD. In cells, GSPs relieved cytotoxicity induced by tau-RD aggregates. Molecular dynamics simulations indicated that strong hydrogen bonding, hydrophobic interaction and 7C -7C stacking between GSPs and tau-RD protein were major reasons why GSPs had high inhibitory activity on tau-RD fibrillogenesis. These results provide preliminary data to develop GSPs into medicines, foodstuffs or nutritional supplements for AD patients, suggesting that GSPs could be a candidate molecule in the drug design for AD therapeutics.(c) 2022 Chemical Industry and Engineering Society of China (CIESC) and Chemical Industry Press (CIP) Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 71
页数:9
相关论文
共 50 条
  • [21] Xanthohumol inhibits tau protein aggregation and protects cells against tau aggregates
    Zhang, Mohan
    Wu, Qiuping
    Yao, Xuanbao
    Zhao, Junyi
    Zhong, Weicong
    Liu, Qiong
    Xiao, Shifeng
    FOOD & FUNCTION, 2019, 10 (12) : 7865 - 7874
  • [22] Author Correction: Tau binding protein CAPON induces tau aggregation and neurodegeneration
    Shoko Hashimoto
    Yukio Matsuba
    Naoko Kamano
    Naomi Mihira
    Naruhiko Sahara
    Jiro Takano
    Shin-ichi Muramatsu
    Takaomi C. Saido
    Takashi Saito
    Nature Communications, 10
  • [23] Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine
    Nadimidla, Keerthi
    Ismail, Tania
    Kanapathipillai, Mathumai
    BIOPOLYMERS, 2017, 107 (09)
  • [24] Tau Aggregation
    Hernandez, Felix
    Ferrer, Isidro
    Perez, Mar
    Zabala, Juan Carlos
    del Rio, Jose Antonio
    Avila, Jesus
    NEUROSCIENCE, 2023, 518 : 64 - 69
  • [25] Structure of tau protein and assembly into paired helical filaments
    Friedhoff, P
    von Bergen, M
    Mandelkow, EM
    Mandelkow, E
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01): : 122 - 132
  • [26] Tau protein, the main component of paired helical filaments
    Avila, Jesus
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 : 171 - 175
  • [27] Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments
    Barghorn, S
    Mandelkow, E
    BIOCHEMISTRY, 2002, 41 (50) : 14885 - 14896
  • [28] In vitro aggregation of the tau protein and its inhibition
    Janockova, J.
    Gorecky, L.
    Korabecny, J.
    Bolognesi, M. L.
    Bartolini, M.
    Soukup, O.
    FEBS OPEN BIO, 2019, 9 : 223 - 223
  • [29] Tau cleavage and tau aggregation in neurodegenerative disease
    Hanger, Diane P.
    Wray, Selina
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 1016 - 1020
  • [30] Binding of Hsp90 to Tau Promotes a Conformational Change and Aggregation of Tau Protein
    Tortosa, Elena
    Santa-Maria, Ismael
    Moreno, Francisco
    Lim, Filip
    Perez, Mar
    Avila, Jesus
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (02) : 319 - 325